AtriCure

AtriCure PEG

The PEG Ratio (Price/Earnings-to-Growth) of AtriCure (ATRC) as of Oct 9, 2026 is -3.17.

PEG

-3.17

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of AtriCure is 2025 -3.17 . PEG Ratio (Price/Earnings-to-Growth) of AtriCure was 2024 - . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

AtriCure Stock analysis

What does AtriCure do? AtriCure Inc is a medical technology company that specializes in the development of innovative products and therapies for the treatment of cardiac arrhythmias. It was founded in 2000 and is headquartered in Mason, Ohio, USA. The company offers a wide range of products and therapies, including the isolation of pulmonary veins, catheter technology, radiofrequency ablation, and innovative solutions for the treatment of heart valve diseases and other structural heart problems. AtriCure is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AtriCure stock

PEG Ratio (Price/Earnings-to-Growth) of AtriCure is -3.17 in 2025.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) AtriCure since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s AtriCure with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — AtriCure

All Key Metrics — AtriCure